2 Core Reasons Tesla Investors Should Be Getting Nervous
Axe Cap view
Why Tesla’s Hype May Be Fading
Tesla’s EV production milestone hides growing cracks in product competitiveness and autonomy ambitions.
Tesla’s milestone of 10 million electric vehicles is impressive but masks two worrying trends. First, Tesla’s autonomous driving efforts lag far behind competitors like Waymo and Baidu, who have logged hundreds of millions of fully driverless miles and secured clearer regulatory approvals. Tesla’s robotaxi ambitions are stalling without a clear timeline for government clearance on its Cybercab. Second, their core automotive business is showing signs of strain with deliveries declining two years running. That points to an aging product lineup and increased margin pressure from fierce competition and price cuts. For JSE investors, the lesson is to watch how this plays out against local tech exposures or sectors sensitive to innovation trends, like Barloworld’s industrial equipment or Motus’ auto retail footprint. If Tesla stumbles, it could slow enthusiasm for high-growth tech stories globally, tightening risk appetite and possibly strengthening the USD/ZAR as investors seek safe assets. The view may be wrong if Tesla quickly rejuvenates its product line or breaks regulatory ground on autonomy, but currently caution is justified. this is just our opinion and not financial advice
Avoid direct exposure to Tesla-related tech plays for now and position selectively in South African industrials and automotive stocks that could benefit from technology adoption, like Barloworld and Motus, while keeping an eye on USD/ZAR as a risk barometer.
- TSLA
- USD/ZAR
- Barloworld
- Motus
- Tesla launching a breakthrough autonomous vehicle or Cybercab approval
- Renewed demand for Tesla’s core EV product line
6/10
Despite Tesla's milestone of producing 10 million EVs, investors should be concerned about two key issues: the company's robotaxi business significantly lags competitors like Waymo and Baidu in autonomous miles and regulatory approvals, while its core automotive business faces declining deliveries for two consecutive years due to an aging product lineup and intense competition pressuring margins.
Our take is based on reporting first published by The Motley Fool.